Calidi Biotherapeutics Inc. Earnings

The next earnings date for Calidi Biotherapeutics Inc. has not yet been scheduled.

Analyst Estimates of Calidi Biotherapeutics Inc. Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Calidi Biotherapeutics Inc. Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
04/01/2025---$-0.19-24.80%
11/13/2024---$-0.06---
08/14/2024---$-1.402.10%
05/14/2024After Market$-0.2028.57%
03/15/2024After Market$-0.48-140.00%
11/14/2023After Market$-0.1417.65%
08/30/2023---$-0.43---
03/31/2023---$-0.26---
11/14/2022---$0.02---
08/10/2022---$0.14---
05/11/2022---$0.05---
03/31/2022---$0.15---
11/12/2021---$-0.03---
09/13/2021---$0---

More About Calidi Biotherapeutics Inc.

Country
USA
Full Time Employees
29

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Calidi Biotherapeutics Inc. Earnings” Can Refer to the Calidi Biotherapeutics Inc. Earnings Date

Some people say “Calidi Biotherapeutics Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Calidi Biotherapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Calidi Biotherapeutics Inc. Stock on the Earnings Date

If you own Calidi Biotherapeutics Inc. stock (CLDI) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Calidi Biotherapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Calidi Biotherapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Calidi Biotherapeutics Inc. Earnings

You can contact us any time if you would like to ask questions about Calidi Biotherapeutics Inc. earnings or anything else related to the stock market.